Brown Advisory Inc. Raises Stake in Novanta Inc. $NOVT

Brown Advisory Inc. lifted its position in shares of Novanta Inc. (NASDAQ:NOVT) by 0.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 544,172 shares of the technology company’s stock after purchasing an additional 3,901 shares during the quarter. Brown Advisory Inc.’s holdings in Novanta were worth $64,751,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of NOVT. Allspring Global Investments Holdings LLC boosted its holdings in Novanta by 75.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,399,462 shares of the technology company’s stock worth $155,536,000 after acquiring an additional 604,055 shares during the period. GW&K Investment Management LLC boosted its holdings in Novanta by 187.3% in the 4th quarter. GW&K Investment Management LLC now owns 736,954 shares of the technology company’s stock worth $87,691,000 after acquiring an additional 480,413 shares during the period. Norges Bank purchased a new position in Novanta in the 4th quarter worth approximately $50,719,000. Schroder Investment Management Group boosted its holdings in Novanta by 206.1% in the 4th quarter. Schroder Investment Management Group now owns 600,146 shares of the technology company’s stock worth $72,540,000 after acquiring an additional 404,097 shares during the period. Finally, Barrow Hanley Mewhinney & Strauss LLC boosted its holdings in Novanta by 217,908.2% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 346,633 shares of the technology company’s stock worth $41,246,000 after acquiring an additional 346,474 shares during the period. Hedge funds and other institutional investors own 98.35% of the company’s stock.

Novanta Stock Performance

Shares of NOVT opened at $160.53 on Monday. The business’s 50 day moving average is $143.11 and its two-hundred day moving average is $132.85. Novanta Inc. has a 52-week low of $98.27 and a 52-week high of $171.85. The firm has a market cap of $5.72 billion, a price-to-earnings ratio of 116.33 and a beta of 1.67. The company has a quick ratio of 2.69, a current ratio of 3.56 and a debt-to-equity ratio of 0.15.

Novanta (NASDAQ:NOVT) last announced its earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.03. Novanta had a return on equity of 12.06% and a net margin of 5.35%.The company had revenue of $257.71 million for the quarter, compared to analyst estimates of $253.40 million. During the same period in the prior year, the company posted $0.74 EPS. Novanta’s quarterly revenue was up 10.4% on a year-over-year basis. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Analysts forecast that Novanta Inc. will post 3.59 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on NOVT shares. Wall Street Zen cut Novanta from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Robert W. Baird set a $180.00 price target on Novanta in a report on Tuesday, June 9th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a report on Friday, April 17th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Novanta presently has an average rating of “Hold” and a consensus target price of $180.00.

Insider Activity

In related news, CEO Matthijs Glastra sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $150.43, for a total transaction of $1,128,225.00. Following the sale, the chief executive officer directly owned 42,761 shares of the company’s stock, valued at approximately $6,432,537.23. This represents a 14.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.20% of the company’s stock.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.